查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1595520

家禽疫苗市场：按疾病类型、技术和剂型划分 - 全球预测 2025-2030

Poultry Vaccine Market by Disease Type (Infectious Bronchitis, Marek's Disease, New Castle Disease), Technology (Inactivated, Live Attenuated Vaccines, Recombinant), Dosage Form - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年家禽疫苗市场规模为20.7亿美元，预计2024年将达22.3亿美元，复合年增长率为7.86%，预计2030年将达到35.1亿美元。

家禽疫苗市场范围包括旨在预防家禽感染疾病的疫苗的开发、生产和分销，例如禽流感、新城疫和传染性支气管炎。这些疫苗对于确保家禽健康、增强粮食安全和支持家禽业的经济稳定至关重要。家禽疫苗的需求是显而易见的，因为家禽容易感染感染疾病可能造成重大经济损失并危及粮食供应。这些疫苗的最终用途广泛，包括商业家禽养殖场、孵化场和兽医院。

主要市场统计
基准年[2023] 20.7亿美元
预测年份 [2024] 22.3亿美元
预测年份 [2030] 35.1亿美元
复合年增长率（%） 7.86%

该市场的关键成长要素包括家禽疾病发病率的增加、对家禽作为蛋白质来源的需求的增加以及重组疫苗和封装方法等疫苗输送技术的进步。最新的商机源自于对生物安全措施的日益重视和有机农业的成长趋势，这需要强大的疾病预防系统。其中建议是企业应投资更有效的疫苗研发。

阻碍市场开拓的挑战包括严格的监管政策、疫苗开发的高成本以及疫苗分销的低温运输物流。此外，超出目前疫苗接种能力的新出现的疾病也可能构成主要障碍。

创新和研究应着重于开发生产时间较短的疫苗，并探索新方法，例如 mRNA 技术，该技术在人类疫苗中越来越受欢迎。此外，疫苗管理的自动化和数位追踪系统有可能简化业务并改善疫苗影响评估。

市场动态是动态的，其特点是先进的竞争和监管监控。在疫苗开发方面进行创新并利用新技术和资料分析的公司处于有利位置，可以在这一重要领域实现永续成长。

市场动态：揭示快速发展的家禽疫苗市场的关键市场洞察

供需的动态交互作用正在改变家禽疫苗市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 动物疾病发生率增加
    • 世界各地对动物疫苗接种的意识不断增强
    • 全球家禽蛋白消费量增加
  • 市场限制因素
    • 假药的可用性
  • 市场机会
    • 疫苗製造技术的进步
    • 改善食品安全的持续目标和政府积极努力
  • 市场问题
    • 严格的监管核准和合规问题
    • 兽医测试和服务高成本

波特五力：驾驭家禽疫苗市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架描述了评估公司竞争和探索策略机会的清晰方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解家禽疫苗市场的外部影响

外部宏观环境因素对影响家禽疫苗市场的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析：了解家禽疫苗市场的竞争格局

家禽疫苗市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、细分和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵：家禽疫苗市场供应商绩效评估

FPNV定位矩阵是评估家禽疫苗市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议：绘製家禽疫苗市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对家禽疫苗市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

该报告对涵盖关键焦点细分市场的市场进行了全面分析。

1.市场渗透率：对当前市场环境的详细审查，主要企业的广泛资料，评估他们在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有细分市场的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、主要产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策。

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品和地区提供最佳投资机会？

3.塑造市场的关键技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 动物疾病发生率增加
      • 全球动物疫苗接种意识增强
      • 全球鸡肉蛋白消费量增加
    • 抑制因素
      • 假药的可用性
    • 机会
      • 疫苗生产技术进步
      • 改善食品安全的持续目标和首选政府倡议
    • 任务
      • 严格的监管核准和合规问题
      • 兽医测试和服务高成本
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 经济
    • 社会
    • 科技
    • 法律
    • 环境

第六章家禽疫苗市场：依疾病类型

  • 介绍
  • 传染性支气管炎
  • 马立克氏症
  • 新城疫

第七章家禽疫苗市场：依技术分类

  • 介绍
  • 惰性
  • 减毒活疫苗
  • 重组
  • 类毒素

第八章家禽疫苗市场：以剂型分类

  • 介绍
  • 冷冻干燥
  • 液体

第九章美洲家禽疫苗市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太地区家禽疫苗市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲家禽疫苗市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Adnimalis Group
  • Anicon Labor GmbH
  • Bayer AG
  • Biovac Ltd.
  • Biovet Private Limited
  • Boehringer Ingelheim International GmbH
  • Eli Lilly and Company
  • Life Circle Nutrition AG
  • Medicavet
  • Merck & Co., Inc.
  • Nutriment Health Pty. Ltd.
  • Phibro Animal Health Corporation
  • Qilu Animal Health Products Co., Ltd.
  • Virbac Group
  • Zoetis Inc.
Product Code: MRR-0375F3EA9C41

The Poultry Vaccine Market was valued at USD 2.07 billion in 2023, expected to reach USD 2.23 billion in 2024, and is projected to grow at a CAGR of 7.86%, to USD 3.51 billion by 2030.

The scope of the poultry vaccine market encompasses the development, production, and distribution of vaccines aimed at preventing infectious diseases in poultry, such as avian influenza, Newcastle disease, and infectious bronchitis. These vaccines are critical for ensuring poultry health, enhancing food security, and supporting the economic stability of the poultry industry. The necessity for poultry vaccines is underscored by the high susceptibility of poultry to infectious diseases that can lead to significant economic losses and compromise food supplies. The application of these vaccines is widespread, with end-use markets spanning across commercial poultry farms, hatcheries, and veterinary clinics.

KEY MARKET STATISTICS
Base Year [2023] USD 2.07 billion
Estimated Year [2024] USD 2.23 billion
Forecast Year [2030] USD 3.51 billion
CAGR (%) 7.86%

Key growth factors for this market include increasing incidences of poultry diseases, growing demand for poultry as a protein source, and advancements in vaccine delivery technologies such as recombinant vaccines and encapsulation methods. The latest opportunities arise from increased emphasis on biosecurity measures and the rising trend of organic farming, which requires robust disease prevention systems. Among the recommendations is the need for companies to invest in R&D for more efficient vaccines, such as those that provide broader protection and longer-lasting immunity.

Challenges hindering market growth include stringent regulatory policies, high costs associated with vaccine development, and cold chain logistics for vaccine distribution. Furthermore, emerging diseases that outpace current vaccine capabilities can also pose significant barriers.

Innovation and research should focus on developing vaccines with shorter production times and exploring novel methods like mRNA technologies, which have gained prominence in human vaccines. Additionally, automation and digital tracking systems for vaccine administration could streamline operations and improve vaccine impact assessment.

The poultry vaccine market is dynamic, characterized by a high level of competition and regulatory oversight. Businesses that innovate in vaccine development and utilize emerging technologies and data analytics are well-positioned to achieve sustainable growth in this essential sector.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Poultry Vaccine Market

The Poultry Vaccine Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidence of animal diseases
    • Surge in awareness on animal vaccination globally
    • Rising consumption of poultry protein worldwide
  • Market Restraints
    • Availability of counterfeit medicine
  • Market Opportunities
    • Technological advancements for vaccine manufacturing
    • Ongoing aim to increase food safety coupled with favorable government initiatives
  • Market Challenges
    • Strict regulatory approval and compliance concerns
    • High cost of veterinary testing and services

Porter's Five Forces: A Strategic Tool for Navigating the Poultry Vaccine Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Poultry Vaccine Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Poultry Vaccine Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Poultry Vaccine Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Poultry Vaccine Market

A detailed market share analysis in the Poultry Vaccine Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Poultry Vaccine Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Poultry Vaccine Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Poultry Vaccine Market

A strategic analysis of the Poultry Vaccine Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Poultry Vaccine Market, highlighting leading vendors and their innovative profiles. These include Adnimalis Group, Anicon Labor GmbH, Bayer AG, Biovac Ltd., Biovet Private Limited, Boehringer Ingelheim International GmbH, Eli Lilly and Company, Life Circle Nutrition AG, Medicavet, Merck & Co., Inc., Nutriment Health Pty. Ltd., Phibro Animal Health Corporation, Qilu Animal Health Products Co., Ltd., Virbac Group, and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Poultry Vaccine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Disease Type, market is studied across Infectious Bronchitis, Marek's Disease, and New Castle Disease.
  • Based on Technology, market is studied across Inactivated, Live Attenuated Vaccines, Recombinant, and Toxoid.
  • Based on Dosage Form, market is studied across Freeze Dried Vaccines and Liquid.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of animal diseases
      • 5.1.1.2. Surge in awareness on animal vaccination globally
      • 5.1.1.3. Rising consumption of poultry protein worldwide
    • 5.1.2. Restraints
      • 5.1.2.1. Availability of counterfeit medicine
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements for vaccine manufacturing
      • 5.1.3.2. Ongoing aim to increase food safety coupled with favorable government initiatives
    • 5.1.4. Challenges
      • 5.1.4.1. Strict regulatory approval and compliance concerns
      • 5.1.4.2. High cost of veterinary testing and services
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Poultry Vaccine Market, by Disease Type

  • 6.1. Introduction
  • 6.2. Infectious Bronchitis
  • 6.3. Marek's Disease
  • 6.4. New Castle Disease

7. Poultry Vaccine Market, by Technology

  • 7.1. Introduction
  • 7.2. Inactivated
  • 7.3. Live Attenuated Vaccines
  • 7.4. Recombinant
  • 7.5. Toxoid

8. Poultry Vaccine Market, by Dosage Form

  • 8.1. Introduction
  • 8.2. Freeze Dried Vaccines
  • 8.3. Liquid

9. Americas Poultry Vaccine Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Poultry Vaccine Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Poultry Vaccine Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Adnimalis Group
  • 2. Anicon Labor GmbH
  • 3. Bayer AG
  • 4. Biovac Ltd.
  • 5. Biovet Private Limited
  • 6. Boehringer Ingelheim International GmbH
  • 7. Eli Lilly and Company
  • 8. Life Circle Nutrition AG
  • 9. Medicavet
  • 10. Merck & Co., Inc.
  • 11. Nutriment Health Pty. Ltd.
  • 12. Phibro Animal Health Corporation
  • 13. Qilu Animal Health Products Co., Ltd.
  • 14. Virbac Group
  • 15. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. POULTRY VACCINE MARKET RESEARCH PROCESS
  • FIGURE 2. POULTRY VACCINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL POULTRY VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL POULTRY VACCINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL POULTRY VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS POULTRY VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS POULTRY VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES POULTRY VACCINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES POULTRY VACCINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA POULTRY VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA POULTRY VACCINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. POULTRY VACCINE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. POULTRY VACCINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. POULTRY VACCINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL POULTRY VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL POULTRY VACCINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL POULTRY VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. POULTRY VACCINE MARKET DYNAMICS
  • TABLE 7. GLOBAL POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL POULTRY VACCINE MARKET SIZE, BY INFECTIOUS BRONCHITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL POULTRY VACCINE MARKET SIZE, BY MAREK'S DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL POULTRY VACCINE MARKET SIZE, BY NEW CASTLE DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL POULTRY VACCINE MARKET SIZE, BY INACTIVATED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL POULTRY VACCINE MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL POULTRY VACCINE MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL POULTRY VACCINE MARKET SIZE, BY TOXOID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL POULTRY VACCINE MARKET SIZE, BY FREEZE DRIED VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL POULTRY VACCINE MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS POULTRY VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES POULTRY VACCINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC POULTRY VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA POULTRY VACCINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM POULTRY VACCINE MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM POULTRY VACCINE MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM POULTRY VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
  • TABLE 146. POULTRY VACCINE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. POULTRY VACCINE MARKET, FPNV POSITIONING MATRIX, 2023